EIF3A and cancer: It has also been shown that eIF3a knockdown reverses malignant phenotype of cancer cells [17,25], yet paradoxically increases their resistance to DNA-damaging chemotherapeutics by upregulating synthesis of DNA damage repair proteins [19–22].